使用静脉注射免疫球蛋白(IVIG)治疗成人。

Allergy proceedings : the official journal of regional and state allergy societies Pub Date : 1994-11-01 DOI:10.2500/108854194778816445

H G Herrod

{"title":"使用静脉注射免疫球蛋白(IVIG)治疗成人。","authors":"H G Herrod","doi":"10.2500/108854194778816445","DOIUrl":null,"url":null,"abstract":"Although intravenous immunoglobulin (IVIG) has primarily been recognized as useful in patients with antibody deficiencies, it continues to be used for an ever-expanding list of conditions. In addition to antibody replacement, IVIG may act as an immune modulator in certain autoimmune and inflammatory conditions. Its use should be carefully weighed against the high cost of the product. In conditions where it appears to be useful, controlled studies are necessary to prove its efficacy and its cost benefits.","PeriodicalId":7423,"journal":{"name":"Allergy proceedings : the official journal of regional and state allergy societies","volume":"15 6","pages":"309-12"},"PeriodicalIF":0.0000,"publicationDate":"1994-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2500/108854194778816445","citationCount":"7","resultStr":"{\"title\":\"Use of intravenous immunoglobulin (IVIG) therapy in adults.\",\"authors\":\"H G Herrod\",\"doi\":\"10.2500/108854194778816445\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Although intravenous immunoglobulin (IVIG) has primarily been recognized as useful in patients with antibody deficiencies, it continues to be used for an ever-expanding list of conditions. In addition to antibody replacement, IVIG may act as an immune modulator in certain autoimmune and inflammatory conditions. Its use should be carefully weighed against the high cost of the product. In conditions where it appears to be useful, controlled studies are necessary to prove its efficacy and its cost benefits.\",\"PeriodicalId\":7423,\"journal\":{\"name\":\"Allergy proceedings : the official journal of regional and state allergy societies\",\"volume\":\"15 6\",\"pages\":\"309-12\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1994-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.2500/108854194778816445\",\"citationCount\":\"7\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Allergy proceedings : the official journal of regional and state allergy societies\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2500/108854194778816445\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Allergy proceedings : the official journal of regional and state allergy societies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2500/108854194778816445","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 7

摘要

虽然静脉注射免疫球蛋白(IVIG)主要被认为对抗体缺乏的患者有用，但它继续被用于越来越多的疾病。除了抗体替代，IVIG可能在某些自身免疫和炎症条件下作为免疫调节剂。应该仔细权衡它的使用和产品的高成本。在似乎有用的情况下，有必要进行对照研究，以证明其有效性和成本效益。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Use of intravenous immunoglobulin (IVIG) therapy in adults.

Although intravenous immunoglobulin (IVIG) has primarily been recognized as useful in patients with antibody deficiencies, it continues to be used for an ever-expanding list of conditions. In addition to antibody replacement, IVIG may act as an immune modulator in certain autoimmune and inflammatory conditions. Its use should be carefully weighed against the high cost of the product. In conditions where it appears to be useful, controlled studies are necessary to prove its efficacy and its cost benefits.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Allergy proceedings : the official journal of regional and state allergy societies

自引率

0.00%

发文量